Pharmaceutical Business review

Icon establishes new facility in India

The purpose-built, 15,000 square feet facility expands Icon Central Laboratories’s existing network of laboratories located in Farmingdale, New York; Dublin, Ireland and Singapore. The new laboratory is in the process of receiving College of American Pathologists and National Accreditation Board for Laboratory Testing accreditation, the company said.

Icon has also appointed Anuradha Rajput to the position of general manager, Icon Central Laboratories India. Dr Rajput joins Icon Central Laboratories after eight years with Clinigene International, where she held the position of general manager and laboratory director. Dr Rajput has proven expertise in laboratory operations, business development, logistics, quality assurance processes and HR management.

Bob Scott-Edwards, president of Icon Central Laboratories, said: “Having a fully-owned facility in India provides clients with the reassurance that our core laboratory services, ranging from sample management and testing to final data transfer, adhere to our stringent global quality standards.

“We also offer a test menu that is second to none, which avoids the need to export samples and makes Icon a one-stop-shop for clients looking to conduct complex clinical trials in India.”